

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.73696125 |
| 2 | adhesion of symbiont to host cell (GO:0044650) | 6.49963469 |
| 3 | virion attachment to host cell (GO:0019062) | 6.49963469 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.47793699 |
| 5 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 6.35680109 |
| 6 | adhesion of symbiont to host (GO:0044406) | 5.65502493 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.39718017 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.39718017 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.39718017 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.39718017 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.39718017 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.39718017 |
| 13 | respiratory burst (GO:0045730) | 5.16078954 |
| 14 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.09774131 |
| 15 | phagocytosis, recognition (GO:0006910) | 5.06266463 |
| 16 | eosinophil chemotaxis (GO:0048245) | 4.90675608 |
| 17 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.88716136 |
| 18 | superoxide anion generation (GO:0042554) | 4.81119422 |
| 19 | granulocyte activation (GO:0036230) | 4.65208598 |
| 20 | glycosphingolipid catabolic process (GO:0046479) | 4.60662550 |
| 21 | cellular extravasation (GO:0045123) | 4.59125668 |
| 22 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.58770974 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.52339642 |
| 24 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.44309384 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.44028964 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.42236490 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 4.38821734 |
| 28 | eosinophil migration (GO:0072677) | 4.33611899 |
| 29 | reactive oxygen species biosynthetic process (GO:1903409) | 4.31419924 |
| 30 | complement activation, classical pathway (GO:0006958) | 4.28998226 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 4.28638114 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 4.28164135 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 4.27144713 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.26931696 |
| 35 | neutrophil activation (GO:0042119) | 4.21095684 |
| 36 | glycolipid catabolic process (GO:0019377) | 4.17700394 |
| 37 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.15049413 |
| 38 | response to peptidoglycan (GO:0032494) | 4.03565810 |
| 39 | natural killer cell mediated immunity (GO:0002228) | 4.02899326 |
| 40 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.02899326 |
| 41 | positive regulation of mast cell degranulation (GO:0043306) | 4.01349398 |
| 42 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.01349398 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.99208494 |
| 44 | positive regulation of macrophage cytokine production (GO:0060907) | 3.98353045 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.95239108 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.94301583 |
| 47 | phagosome maturation (GO:0090382) | 3.92281310 |
| 48 | cellular response to zinc ion (GO:0071294) | 3.90034393 |
| 49 | regulation of cholesterol storage (GO:0010885) | 3.88655908 |
| 50 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.85675287 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.82373875 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.80818265 |
| 53 | monocyte chemotaxis (GO:0002548) | 3.77062456 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.70860256 |
| 55 | ceramide catabolic process (GO:0046514) | 3.67879938 |
| 56 | low-density lipoprotein particle clearance (GO:0034383) | 3.61754780 |
| 57 | pinocytosis (GO:0006907) | 3.57508127 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.55839007 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.55371253 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.51203757 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49406726 |
| 62 | response to host immune response (GO:0052572) | 3.49406726 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.49324942 |
| 64 | angiotensin maturation (GO:0002003) | 3.49084689 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.48862503 |
| 66 | oligosaccharide catabolic process (GO:0009313) | 3.46625173 |
| 67 | defense response to protozoan (GO:0042832) | 3.45492839 |
| 68 | regulation of monocyte chemotaxis (GO:0090025) | 3.44808539 |
| 69 | positive regulation of bone remodeling (GO:0046852) | 3.43612975 |
| 70 | positive regulation of bone resorption (GO:0045780) | 3.43612975 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.42674479 |
| 72 | complement activation (GO:0006956) | 3.41791997 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 3.41417965 |
| 74 | glomerular filtration (GO:0003094) | 3.35669679 |
| 75 | germinal center formation (GO:0002467) | 3.32690921 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 3.31676740 |
| 77 | macrophage activation (GO:0042116) | 3.28603208 |
| 78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.26562359 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25311336 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.22764605 |
| 81 | detection of molecule of bacterial origin (GO:0032490) | 3.22494182 |
| 82 | apoptotic cell clearance (GO:0043277) | 3.22362656 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 3.20939691 |
| 84 | regulation of chemokine biosynthetic process (GO:0045073) | 3.20731063 |
| 85 | microglial cell activation (GO:0001774) | 3.20519011 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18225451 |
| 87 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.17529557 |
| 88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.17523945 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16232554 |
| 90 | mannose metabolic process (GO:0006013) | 3.15311910 |
| 91 | B cell mediated immunity (GO:0019724) | 3.12083310 |
| 92 | cellular response to interferon-gamma (GO:0071346) | 3.11537954 |
| 93 | neutrophil chemotaxis (GO:0030593) | 3.11503666 |
| 94 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11317665 |
| 95 | macrophage chemotaxis (GO:0048246) | 3.10599904 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 3.10474171 |
| 97 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.10327405 |
| 98 | response to muramyl dipeptide (GO:0032495) | 3.09073871 |
| 99 | positive regulation of interferon-beta production (GO:0032728) | 3.07662820 |
| 100 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.06801770 |
| 101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06282708 |
| 102 | negative regulation of mast cell activation (GO:0033004) | 3.06282699 |
| 103 | myeloid leukocyte activation (GO:0002274) | 3.05993362 |
| 104 | barbed-end actin filament capping (GO:0051016) | 3.05959520 |
| 105 | sphingolipid catabolic process (GO:0030149) | 3.05795794 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05482834 |
| 107 | detection of other organism (GO:0098543) | 3.05120545 |
| 108 | positive regulation of interleukin-12 production (GO:0032735) | 3.05087219 |
| 109 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.03984410 |
| 110 | detection of bacterium (GO:0016045) | 3.03845407 |
| 111 | membrane lipid catabolic process (GO:0046466) | 3.03709089 |
| 112 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.03484264 |
| 113 | neutrophil migration (GO:1990266) | 3.02889984 |
| 114 | dendritic cell differentiation (GO:0097028) | 3.02186000 |
| 115 | renal filtration (GO:0097205) | 3.02124375 |
| 116 | positive regulation of lipid storage (GO:0010884) | 3.01052182 |
| 117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00653208 |
| 118 | regulation of vitamin metabolic process (GO:0030656) | 3.00652595 |
| 119 | response to host defenses (GO:0052200) | 2.98383443 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98383443 |
| 121 | response to host (GO:0075136) | 2.98383443 |
| 122 | peptide catabolic process (GO:0043171) | 2.97391388 |
| 123 | response to interferon-gamma (GO:0034341) | 2.96491519 |
| 124 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.95997149 |
| 125 | lymphocyte chemotaxis (GO:0048247) | 2.95925130 |
| 126 | positive regulation of interleukin-6 production (GO:0032755) | 2.95541120 |
| 127 | leukocyte mediated cytotoxicity (GO:0001909) | 2.92386187 |
| 128 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91919748 |
| 129 | regulation of type 2 immune response (GO:0002828) | 2.91275403 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.91167540 |
| 131 | regulation of hypersensitivity (GO:0002883) | 2.90490312 |
| 132 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90296293 |
| 133 | superoxide metabolic process (GO:0006801) | 2.89514609 |
| 134 | response to protozoan (GO:0001562) | 2.88596201 |
| 135 | positive regulation of lymphocyte migration (GO:2000403) | 2.88366367 |
| 136 | regulation of leukocyte degranulation (GO:0043300) | 2.87664836 |
| 137 | regulation of macrophage cytokine production (GO:0010935) | 2.86803936 |
| 138 | lipoxygenase pathway (GO:0019372) | 2.86344127 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.85865907 |
| 140 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85389037 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84712833 |
| 142 | positive regulation of heat generation (GO:0031652) | 2.84041224 |
| 143 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81873580 |
| 144 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.81694120 |
| 145 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.81479738 |
| 146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80970559 |
| 147 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.79055439 |
| 148 | type I interferon signaling pathway (GO:0060337) | 2.75683915 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.75683915 |
| 150 | regulation of cellular extravasation (GO:0002691) | 2.73914043 |
| 151 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73247768 |
| 152 | response to type I interferon (GO:0034340) | 2.72083284 |
| 153 | T cell costimulation (GO:0031295) | 2.70204672 |
| 154 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.69307612 |
| 155 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.67696620 |
| 156 | dendritic cell chemotaxis (GO:0002407) | 2.67472927 |
| 157 | lymphocyte costimulation (GO:0031294) | 2.65750020 |
| 158 | NIK/NF-kappaB signaling (GO:0038061) | 2.65172250 |
| 159 | protein localization to endosome (GO:0036010) | 2.64988987 |
| 160 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.64829430 |
| 161 | positive regulation of neutrophil migration (GO:1902624) | 2.64829430 |
| 162 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.64058818 |
| 163 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.64058818 |
| 164 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.64058818 |
| 165 | regulation of T cell tolerance induction (GO:0002664) | 2.59286458 |
| 166 | positive regulation of respiratory burst (GO:0060267) | 2.57912074 |
| 167 | osteoclast differentiation (GO:0030316) | 2.57470555 |
| 168 | positive regulation of tissue remodeling (GO:0034105) | 2.56210477 |
| 169 | detection of external biotic stimulus (GO:0098581) | 2.55566807 |
| 170 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.54865196 |
| 171 | amino sugar catabolic process (GO:0046348) | 2.54095831 |
| 172 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.51846613 |
| 173 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51765559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.89746593 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.36805008 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.81881452 |
| 4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.91355971 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.63551703 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.30196345 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85939918 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.60121000 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18925362 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13683701 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01873787 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91043060 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88783695 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.65083420 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63133137 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51818075 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20462850 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19139439 |
| 19 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.11733951 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01565270 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99779698 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99163830 |
| 23 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.94779456 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94298913 |
| 25 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75258760 |
| 26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.74041530 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70159491 |
| 28 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69258216 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58462171 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58462171 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56594318 |
| 32 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52904364 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48666913 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42936099 |
| 35 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42681674 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41706333 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38427910 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35720689 |
| 39 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.35582241 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35522725 |
| 41 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34688646 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32400513 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30681830 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30560009 |
| 45 | * MYB_26560356_Chip-Seq_TH2_Human | 1.29759151 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28230698 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27383015 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25114621 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22502328 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21379457 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20961108 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20908003 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19773743 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19046252 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18471614 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15319579 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15253205 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12846110 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12270726 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10977224 |
| 61 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09603777 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09243515 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07433216 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05050505 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04871844 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04739439 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02096910 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02003609 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01343981 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01315211 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97157072 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96482901 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96212300 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96103526 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95455880 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94376763 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93540979 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93464252 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92689557 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 0.92662177 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 0.92627899 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92324965 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90819207 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90447242 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90062734 |
| 86 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89806878 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88981721 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88924341 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88295848 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87916993 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87266525 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86179947 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85252590 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84869901 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84334495 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83944423 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83944423 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82417698 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81307450 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80401489 |
| 101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79224275 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78445092 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77066737 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76676112 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76634013 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76416652 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75532009 |
| 108 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74934259 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73329875 |
| 110 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.73024921 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72993852 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.72974008 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70175118 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68840925 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67709360 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67569358 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65545494 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.65390665 |
| 119 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64755900 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63682527 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61080498 |
| 122 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.59873835 |
| 123 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59316118 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56754701 |
| 125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56151755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.77883529 |
| 2 | MP0003303_peritoneal_inflammation | 4.35623681 |
| 3 | MP0003436_decreased_susceptibility_to | 4.30036065 |
| 4 | MP0006082_CNS_inflammation | 4.20766125 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.92830209 |
| 6 | MP0009785_altered_susceptibility_to | 3.62039947 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.45603151 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.33370709 |
| 9 | * MP0005025_abnormal_response_to | 3.03393109 |
| 10 | MP0003724_increased_susceptibility_to | 2.90405138 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.84225241 |
| 12 | MP0005671_abnormal_response_to | 2.68748397 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.64259908 |
| 14 | MP0008004_abnormal_stomach_pH | 2.56960241 |
| 15 | MP0002723_abnormal_immune_serum | 2.41117706 |
| 16 | MP0001853_heart_inflammation | 2.27841162 |
| 17 | MP0004510_myositis | 2.23757283 |
| 18 | MP0005387_immune_system_phenotype | 2.21740532 |
| 19 | MP0001790_abnormal_immune_system | 2.21740532 |
| 20 | MP0003690_abnormal_glial_cell | 2.16281518 |
| 21 | * MP0001819_abnormal_immune_cell | 2.14817271 |
| 22 | MP0001800_abnormal_humoral_immune | 2.14269843 |
| 23 | MP0000685_abnormal_immune_system | 2.11281430 |
| 24 | * MP0002420_abnormal_adaptive_immunity | 2.09834588 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.08888563 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.07289672 |
| 27 | MP0002405_respiratory_system_inflammati | 2.05471546 |
| 28 | MP0003448_altered_tumor_morphology | 2.02251980 |
| 29 | MP0000343_altered_response_to | 2.00727533 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.98790479 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.95455782 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.89436443 |
| 33 | MP0009764_decreased_sensitivity_to | 1.89367358 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.86537866 |
| 35 | MP0003075_altered_response_to | 1.84699294 |
| 36 | MP0010386_abnormal_urinary_bladder | 1.84607481 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.77136724 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.75671537 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.68648984 |
| 40 | MP0004947_skin_inflammation | 1.61992813 |
| 41 | MP0005310_abnormal_salivary_gland | 1.58829894 |
| 42 | MP0008469_abnormal_protein_level | 1.56343807 |
| 43 | MP0000604_amyloidosis | 1.56189790 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.51526830 |
| 45 | * MP0005166_decreased_susceptibility_to | 1.45547265 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.45363628 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.44886959 |
| 48 | MP0000716_abnormal_immune_system | 1.41322983 |
| 49 | MP0001851_eye_inflammation | 1.40980988 |
| 50 | MP0003186_abnormal_redox_activity | 1.39307114 |
| 51 | MP0000858_altered_metastatic_potential | 1.37287154 |
| 52 | MP0005164_abnormal_response_to | 1.30816966 |
| 53 | MP0005647_abnormal_sex_gland | 1.25637194 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.25060075 |
| 55 | MP0002006_tumorigenesis | 1.23610277 |
| 56 | MP0003828_pulmonary_edema | 1.22568066 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.22329713 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.21770993 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.20017620 |
| 60 | MP0002398_abnormal_bone_marrow | 1.17000044 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.14621733 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.14621733 |
| 63 | MP0003329_amyloid_beta_deposits | 1.13073886 |
| 64 | MP0004130_abnormal_muscle_cell | 1.09327107 |
| 65 | MP0002429_abnormal_blood_cell | 1.09117594 |
| 66 | MP0001849_ear_inflammation | 1.05834750 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.04794931 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.04581278 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.02789624 |
| 70 | MP0005023_abnormal_wound_healing | 1.02363134 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.99471525 |
| 72 | MP0009763_increased_sensitivity_to | 0.99456307 |
| 73 | MP0005165_increased_susceptibility_to | 0.99259635 |
| 74 | MP0002090_abnormal_vision | 0.98630507 |
| 75 | MP0005390_skeleton_phenotype | 0.96749767 |
| 76 | MP0009840_abnormal_foam_cell | 0.96424062 |
| 77 | MP0003866_abnormal_defecation | 0.94863237 |
| 78 | MP0001542_abnormal_bone_strength | 0.94844811 |
| 79 | MP0008260_abnormal_autophagy | 0.93970809 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.93358079 |
| 81 | MP0010307_abnormal_tumor_latency | 0.93100671 |
| 82 | MP0000371_diluted_coat_color | 0.92604657 |
| 83 | MP0002254_reproductive_system_inflammat | 0.91774691 |
| 84 | MP0003195_calcinosis | 0.90765391 |
| 85 | MP0005451_abnormal_body_composition | 0.90210039 |
| 86 | MP0002722_abnormal_immune_system | 0.89079111 |
| 87 | MP0005365_abnormal_bile_salt | 0.86505711 |
| 88 | MP0002971_abnormal_brown_adipose | 0.82785016 |
| 89 | MP0009115_abnormal_fat_cell | 0.81690861 |
| 90 | MP0009278_abnormal_bone_marrow | 0.79544129 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.79521387 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.79186509 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.78300017 |
| 94 | MP0002933_joint_inflammation | 0.76885446 |
| 95 | MP0003795_abnormal_bone_structure | 0.76372680 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.76265690 |
| 97 | MP0001873_stomach_inflammation | 0.75131672 |
| 98 | MP0004883_abnormal_blood_vessel | 0.75098624 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.74091407 |
| 100 | MP0001663_abnormal_digestive_system | 0.73093949 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.70353549 |
| 102 | MP0005275_abnormal_skin_tensile | 0.70011878 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.69696904 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.69310658 |
| 105 | * MP0000920_abnormal_myelination | 0.67049272 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.66723859 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.66568837 |
| 108 | MP0000249_abnormal_blood_vessel | 0.65498580 |
| 109 | MP0005171_absent_coat_pigmentation | 0.63834820 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.59620337 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.58448017 |
| 112 | MP0003136_yellow_coat_color | 0.58304426 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.57497655 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.53489672 |
| 115 | MP0003091_abnormal_cell_migration | 0.52120986 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.51427042 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.50900067 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.50360471 |
| 119 | MP0001958_emphysema | 0.49252412 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.48991104 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.46093929 |
| 122 | MP0005197_abnormal_uvea_morphology | 0.45186175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.02812754 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.02616805 |
| 3 | Recurrent abscess formation (HP:0002722) | 7.98661628 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 7.16528141 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.94806355 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.74387375 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.43756105 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 5.22863116 |
| 9 | Gingivitis (HP:0000230) | 4.65028421 |
| 10 | Recurrent skin infections (HP:0001581) | 4.60955312 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.55943260 |
| 12 | Obstructive lung disease (HP:0006536) | 4.55943260 |
| 13 | Axonal loss (HP:0003447) | 4.42164487 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.33432009 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.18759289 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.18759289 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.18759289 |
| 18 | Disinhibition (HP:0000734) | 4.17968719 |
| 19 | Stomatitis (HP:0010280) | 4.08781637 |
| 20 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.03251533 |
| 21 | Recurrent fungal infections (HP:0002841) | 4.01631784 |
| 22 | Protuberant abdomen (HP:0001538) | 3.62735831 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.59114571 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57955841 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57955841 |
| 26 | Myositis (HP:0100614) | 3.40684371 |
| 27 | Basal ganglia calcification (HP:0002135) | 3.35262232 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.34526696 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19874339 |
| 30 | Optic neuritis (HP:0100653) | 3.16281818 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.16281818 |
| 32 | Orchitis (HP:0100796) | 3.15086938 |
| 33 | Myocardial infarction (HP:0001658) | 3.09465672 |
| 34 | Cellulitis (HP:0100658) | 3.08244114 |
| 35 | Prostate neoplasm (HP:0100787) | 3.05147747 |
| 36 | Agnosia (HP:0010524) | 3.05121224 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.97308981 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.93755164 |
| 39 | Vasculitis (HP:0002633) | 2.91171814 |
| 40 | Urticaria (HP:0001025) | 2.88863753 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.83850123 |
| 42 | Periodontitis (HP:0000704) | 2.83305493 |
| 43 | Loss of speech (HP:0002371) | 2.83054586 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.79494513 |
| 45 | Mutism (HP:0002300) | 2.77559953 |
| 46 | Recurrent pneumonia (HP:0006532) | 2.75339777 |
| 47 | Complement deficiency (HP:0004431) | 2.74197253 |
| 48 | Recurrent viral infections (HP:0004429) | 2.71639395 |
| 49 | Joint hemorrhage (HP:0005261) | 2.70847883 |
| 50 | Malnutrition (HP:0004395) | 2.70205813 |
| 51 | Increased IgM level (HP:0003496) | 2.70052955 |
| 52 | Nausea (HP:0002018) | 2.66019972 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63884498 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.63884498 |
| 55 | Abnormality of complement system (HP:0005339) | 2.61633732 |
| 56 | Steatorrhea (HP:0002570) | 2.59672436 |
| 57 | Hemoptysis (HP:0002105) | 2.57230063 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.56474314 |
| 59 | Osteomyelitis (HP:0002754) | 2.56357896 |
| 60 | Thick nail (HP:0001805) | 2.55222156 |
| 61 | Upper motor neuron abnormality (HP:0002127) | 2.54574660 |
| 62 | Cheilitis (HP:0100825) | 2.53392729 |
| 63 | Poor head control (HP:0002421) | 2.51743339 |
| 64 | Thin bony cortex (HP:0002753) | 2.50098077 |
| 65 | Spondylolisthesis (HP:0003302) | 2.48329295 |
| 66 | Polygenic inheritance (HP:0010982) | 2.47264267 |
| 67 | Colitis (HP:0002583) | 2.46401020 |
| 68 | Amyloidosis (HP:0011034) | 2.46056254 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.44349078 |
| 70 | Meningitis (HP:0001287) | 2.43966514 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32865298 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32625141 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.32625141 |
| 74 | Hematochezia (HP:0002573) | 2.29627712 |
| 75 | Pustule (HP:0200039) | 2.27016067 |
| 76 | Sepsis (HP:0100806) | 2.26428971 |
| 77 | Thoracic kyphosis (HP:0002942) | 2.25564522 |
| 78 | Fat malabsorption (HP:0002630) | 2.25140116 |
| 79 | Multiple lipomas (HP:0001012) | 2.23266018 |
| 80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23126459 |
| 81 | Inappropriate behavior (HP:0000719) | 2.22971805 |
| 82 | Leukocytosis (HP:0001974) | 2.20729689 |
| 83 | Gingival bleeding (HP:0000225) | 2.19689419 |
| 84 | Abdominal distention (HP:0003270) | 2.17606269 |
| 85 | Peripheral demyelination (HP:0011096) | 2.17421117 |
| 86 | Glomerulonephritis (HP:0000099) | 2.15806267 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15542678 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15542678 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15542678 |
| 90 | Metaphyseal irregularity (HP:0003025) | 2.11570724 |
| 91 | Arterial thrombosis (HP:0004420) | 2.11173951 |
| 92 | Gangrene (HP:0100758) | 2.10470093 |
| 93 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09762437 |
| 94 | Bone pain (HP:0002653) | 2.09579876 |
| 95 | Inflammation of the large intestine (HP:0002037) | 2.09009062 |
| 96 | Pathologic fracture (HP:0002756) | 2.07332086 |
| 97 | Xerostomia (HP:0000217) | 2.03620739 |
| 98 | Nuclear cataract (HP:0100018) | 2.02343786 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01806552 |
| 100 | Hypercholesterolemia (HP:0003124) | 2.01266243 |
| 101 | Tetraparesis (HP:0002273) | 2.01229107 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.00599092 |
| 103 | Diminished motivation (HP:0000745) | 2.00578448 |
| 104 | Petechiae (HP:0000967) | 1.98727085 |
| 105 | Femoral bowing (HP:0002980) | 1.98152595 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 1.94588207 |
| 107 | Gastrointestinal inflammation (HP:0004386) | 1.94515521 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.93848375 |
| 109 | Albinism (HP:0001022) | 1.93654385 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 1.92759141 |
| 111 | Neurofibrillary tangles (HP:0002185) | 1.91991630 |
| 112 | Esophageal varix (HP:0002040) | 1.91685520 |
| 113 | Apathy (HP:0000741) | 1.91668173 |
| 114 | Restrictive lung disease (HP:0002091) | 1.90682836 |
| 115 | Amaurosis fugax (HP:0100576) | 1.89470407 |
| 116 | Conjunctival telangiectasia (HP:0000524) | 1.88548663 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.86396512 |
| 118 | Abnormality of the peritoneum (HP:0002585) | 1.86104636 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.85448672 |
| 120 | Purpura (HP:0000979) | 1.84858658 |
| 121 | Mucosal telangiectasiae (HP:0100579) | 1.84455111 |
| 122 | Neuronal loss in central nervous system (HP:0002529) | 1.78189148 |
| 123 | Abnormality of the lumbar spine (HP:0100712) | 1.77992112 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.77444720 |
| 125 | Pulmonary hypertension (HP:0002092) | 1.77336814 |
| 126 | Bone cyst (HP:0012062) | 1.76672463 |
| 127 | Arthralgia (HP:0002829) | 1.76650884 |
| 128 | T lymphocytopenia (HP:0005403) | 1.76164176 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.76018744 |
| 130 | Abnormality of the prostate (HP:0008775) | 1.75701581 |
| 131 | Personality changes (HP:0000751) | 1.74281037 |
| 132 | Progressive visual loss (HP:0000529) | 1.71868497 |
| 133 | Anorexia (HP:0002039) | 1.69332878 |
| 134 | Nephritis (HP:0000123) | 1.66566109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.78836186 |
| 2 | RIPK4 | 5.70923042 |
| 3 | BLK | 3.94171750 |
| 4 | MAP3K14 | 3.69358602 |
| 5 | NME2 | 3.28336372 |
| 6 | TBK1 | 3.08408257 |
| 7 | IRAK4 | 2.67796141 |
| 8 | CDC42BPA | 2.32448457 |
| 9 | IRAK3 | 2.30597376 |
| 10 | PRPF4B | 2.25416111 |
| 11 | PIM2 | 2.25349475 |
| 12 | MST1R | 2.15740210 |
| 13 | ABL2 | 2.10179331 |
| 14 | NEK9 | 2.08172574 |
| 15 | IKBKB | 2.04208359 |
| 16 | TYK2 | 1.87320372 |
| 17 | TXK | 1.82524807 |
| 18 | MAP4K1 | 1.82360398 |
| 19 | KIT | 1.80265456 |
| 20 | JAK3 | 1.64590462 |
| 21 | ERBB3 | 1.58466116 |
| 22 | GRK7 | 1.52520222 |
| 23 | BMX | 1.50630896 |
| 24 | TRPM7 | 1.47126283 |
| 25 | MST4 | 1.45445656 |
| 26 | DDR2 | 1.43086921 |
| 27 | IKBKE | 1.41889384 |
| 28 | JAK1 | 1.39867072 |
| 29 | BMPR2 | 1.32115166 |
| 30 | FGFR4 | 1.31817527 |
| 31 | SYK | 1.31394215 |
| 32 | STK4 | 1.27514829 |
| 33 | MAP3K13 | 1.20151322 |
| 34 | LYN | 1.19848853 |
| 35 | HCK | 1.15628625 |
| 36 | EPHA3 | 1.14209854 |
| 37 | MARK3 | 1.14204224 |
| 38 | CSK | 1.13317415 |
| 39 | TAOK3 | 1.12245065 |
| 40 | ERN1 | 1.10249644 |
| 41 | JAK2 | 1.08429787 |
| 42 | FGR | 1.06305923 |
| 43 | ZAP70 | 1.05824932 |
| 44 | MAP3K3 | 1.03850984 |
| 45 | ERBB4 | 1.02483669 |
| 46 | PIK3CG | 1.01685406 |
| 47 | CAMKK2 | 1.01593232 |
| 48 | RIPK1 | 1.01336752 |
| 49 | YES1 | 1.00787075 |
| 50 | ADRBK2 | 0.99318341 |
| 51 | PIM1 | 0.98665998 |
| 52 | CAMK1D | 0.98396357 |
| 53 | CHUK | 0.97163880 |
| 54 | LCK | 0.94815132 |
| 55 | BTK | 0.91749542 |
| 56 | TEC | 0.91113322 |
| 57 | PRKG2 | 0.88974688 |
| 58 | MATK | 0.88482395 |
| 59 | STK24 | 0.87444824 |
| 60 | CSF1R | 0.86373035 |
| 61 | PDK2 | 0.82993969 |
| 62 | RPS6KA2 | 0.82913295 |
| 63 | ABL1 | 0.82770240 |
| 64 | LIMK1 | 0.76568156 |
| 65 | PRKCD | 0.75344440 |
| 66 | PDGFRA | 0.74769798 |
| 67 | TESK2 | 0.72739155 |
| 68 | RPS6KA4 | 0.70693121 |
| 69 | TRIB3 | 0.68794239 |
| 70 | EGFR | 0.67430956 |
| 71 | SCYL2 | 0.67393470 |
| 72 | TAOK1 | 0.66468372 |
| 73 | MAP3K6 | 0.62416071 |
| 74 | CAMK1G | 0.62312592 |
| 75 | CDK6 | 0.61988133 |
| 76 | MAP3K5 | 0.61599839 |
| 77 | FER | 0.60095094 |
| 78 | SIK3 | 0.55753538 |
| 79 | MAP3K11 | 0.54392397 |
| 80 | IRAK2 | 0.54093021 |
| 81 | MUSK | 0.53592912 |
| 82 | MAP3K10 | 0.53592476 |
| 83 | MAPK7 | 0.52545164 |
| 84 | DAPK3 | 0.52378220 |
| 85 | MAPKAPK2 | 0.51876127 |
| 86 | FES | 0.51760498 |
| 87 | PAK4 | 0.50799381 |
| 88 | PRKCQ | 0.49802312 |
| 89 | CLK1 | 0.49134752 |
| 90 | EIF2AK2 | 0.48906391 |
| 91 | BMPR1B | 0.47616851 |
| 92 | RPS6KC1 | 0.46549683 |
| 93 | RPS6KL1 | 0.46549683 |
| 94 | MAP3K8 | 0.45693805 |
| 95 | PRKCH | 0.45372274 |
| 96 | PDGFRB | 0.45054569 |
| 97 | CAMKK1 | 0.44734039 |
| 98 | RET | 0.44641156 |
| 99 | IRAK1 | 0.44016583 |
| 100 | FGFR3 | 0.43278449 |
| 101 | MET | 0.40758320 |
| 102 | PKN2 | 0.40460195 |
| 103 | PDPK1 | 0.38872413 |
| 104 | GSK3A | 0.38087977 |
| 105 | DAPK2 | 0.37079972 |
| 106 | MAP3K2 | 0.36463751 |
| 107 | PDK1 | 0.36305094 |
| 108 | FYN | 0.35180956 |
| 109 | ITK | 0.34712580 |
| 110 | TTN | 0.33323436 |
| 111 | MOS | 0.32022076 |
| 112 | STK10 | 0.29646068 |
| 113 | ARAF | 0.29328689 |
| 114 | IGF1R | 0.28834877 |
| 115 | TESK1 | 0.28624768 |
| 116 | TGFBR2 | 0.28128637 |
| 117 | SIK2 | 0.26563665 |
| 118 | EPHB1 | 0.24611064 |
| 119 | ACVR1B | 0.24131480 |
| 120 | MAP3K12 | 0.23785813 |
| 121 | KSR2 | 0.22489961 |
| 122 | MAP3K1 | 0.21753641 |
| 123 | LRRK2 | 0.20413555 |
| 124 | SRC | 0.20389089 |
| 125 | DYRK1B | 0.19717130 |
| 126 | INSR | 0.18561759 |
| 127 | MAP2K3 | 0.17942395 |
| 128 | TAOK2 | 0.17577791 |
| 129 | PLK2 | 0.17348542 |
| 130 | PRKCE | 0.17336821 |
| 131 | STK3 | 0.13758268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.33783510 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27945970 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.17553100 |
| 4 | Phagosome_Homo sapiens_hsa04145 | 2.88060442 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 2.78118250 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.71616678 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.65182614 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.61727875 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.57576485 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55248574 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.47718352 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.38688155 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34209011 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30595555 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29979172 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26606388 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.23769219 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.12565690 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.97491583 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97228449 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.83739530 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76971518 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65946024 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56153854 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.55523193 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54478649 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54318871 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43660845 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41878514 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38821226 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36602733 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.36488551 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32368417 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27766150 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27400511 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23043602 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22953258 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22388175 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22380303 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.19723176 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.19013829 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18965884 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17542848 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10193785 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09970180 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06079731 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02466684 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01578872 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01178062 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00716314 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93507699 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92027580 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.91027828 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87697630 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86931749 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83818319 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83775089 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82397624 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.78491962 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77118550 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74438551 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73189617 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70550286 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67123469 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.64231781 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58564385 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58156779 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57552121 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.57365343 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56748577 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55648656 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.54328777 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53740096 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.53129660 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52758869 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52318470 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50725508 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49222400 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48311853 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44397300 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40211486 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39111762 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37693865 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36930854 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36338094 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36113248 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36066762 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35427687 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34089859 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32459727 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.32240427 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31377684 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31363748 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30498783 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.30397872 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.30372381 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30283623 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27992661 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.27359634 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27213936 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25350888 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23850963 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23500969 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.23104401 |
| 105 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.22544276 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21619047 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21278586 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20100928 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19950438 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19207754 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19098509 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18785399 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18712877 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.18043551 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12932933 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12099836 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09822468 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09366299 |
| 119 | Proteasome_Homo sapiens_hsa03050 | 0.07066822 |

